Title : Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland.

Pub. Date : 2020

PMID : 32922513






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In anti-TNF-exposed population the most effective treatment was TFB. tofacitinib tumor necrosis factor Homo sapiens